13 August 2015 - The first of two dissemination meetings under LinkTADs will take place on 2 September 2015 in Montpellier, France. The objective of the dissemination meeting is for researchers and other stakeholders working on animal health to meet LinkTADs partners, to learn about its activities and main achievements to date, but most importantly, how they can benefit from LinkTADs networking, resources and collaboration opportunities. The agenda of the half-day event can be downloaded here. A second dissemination event will be organized in China later on in 2015.
Launched in November 2013, LinkTADs is a three-year initiative funded by the European Commission’s (EU’s) Seventh Framework Programme (FP7) to coordinate European and Chinese research on animal disease prevention and control. The fight against animal diseases relies heavily on the research community developing new intervention/control tools and strategies. These could be in the form of new vaccines and diagnostics, or through a better knowledge and understanding of the disease to prevent its emergence and spread, and improve approaches to surveillance, prevention and control. It is also paramount that these two disciplines (i.e. laboratory sciences and epidemiology) are linked and coordinated in their work. International collaboration between animal health researchers can speed up these advances by bringing together new ideas, technologies, funds and expertise to solve livestock health challenges, thus optimizing the use of research resources. However, there are also many barriers that challenge joint projects.
LinkTADs First Dissemination Event is organized as a parallel session at the 9th Annual EPIZONE Meeting, Congress Centre “Le Corum” in Montpellier, France on 2-3 September 2015. This year, EPIZONE will be combined with the Xth International Conference of ESVV 2015, ‘Changing viruses in a Changing world’ (31 August – 3 September 2015). The meetings emphasis will be on multidisciplinary approaches for animal disease prevention and control and the recent research advances. They will provide extensive opportunities for networking, scientific exchange and fostering collaborations, particularly with developing countries where the diseases are widespread.